Battered by a steep broad-market selloff this week, Moderna shares fell for a sixth straight day Friday as experts questioned whether Covid-19 vaccine sales alone will help justify the firm’s meteoric valuation, intensifying a crash that’s wiped out more than 60% of the value in one of last year’s top stocks and turned it into this year’s worst performer.
Continued at
https://www.forbes.com/sites/jonath...oosters-arent-halting-omicron-infections/amp/
Continued at
https://www.forbes.com/sites/jonath...oosters-arent-halting-omicron-infections/amp/